Authors: Yu H, Ma L, Chen Y, Liu J, Li L, Yang Z, Xu J, Guo B.
DOI: 10.3389/fmed.2025.1637694
Abstract Summary
New research shows combining four biomarkers—serum ferritin, homocysteine, C-reactive protein, and liver fat ultrasound measurements—significantly improves prediction of metabolic dysfunction-associated steatotic liver disease (MASLD). In a study of 102 MASLD patients versus 106 healthy controls, this multi-marker approach demonstrated superior diagnostic accuracy compared to individual tests alone.
Why Brain? 🧠
Combined serum ferritin, homocysteine, CRP, and ultrasound fat parameters effectively predict metabolic liver disease, offering valuable biomarkers for early diagnosis and clinical intervention.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
